Companies:
50,331
Total Market Cap:
144518950116427.29
BerGenBio ASA
OSL-BGBIO
Healthcare
Biotechnology
Global Rank
#44566
Country Rank
#261
Market Cap
4.4 M
Price
0.11
Change (%)
1.92%
Volume
68,542
BerGenBio ASA's latest marketcap:
4.4 M
As of 08/14/2025, BerGenBio ASA's market capitalization has reached $4.4 M. According to our data, BerGenBio ASA is the 44566th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 4.4 M |
| Revenue (ttm) | 83,282.59 |
| Net Income (ttm) | -13,678,969.18 |
| Shares Out | 39.09 M |
| EPS (ttm) | -0.39 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/20/2025 |
Market Cap Chart
Data Updated: 08/14/2025
BerGenBio ASA's yearly market capitalization.
BerGenBio ASA has seen its market value drop from kr1.03 B to kr44.79 M since 2017, representing a total decrease of 95.67% and an annual compound decline rate (CAGR) of 33.74%.
| Date | Market Cap(kr) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/14/2025 | kr44.79 M | $4.4 M | -85.99% | 44566 |
| 12/30/2024 | kr319.77 M | $28.08 M | -57.22% | 31911 |
| 12/29/2023 | kr747.46 M | $73.39 M | 12.86% | 25175 |
| 12/30/2022 | kr662.29 M | $67.49 M | -63.08% | 24856 |
| 12/30/2021 | kr1.79 B | $203.17 M | -36.16% | 18765 |
| 12/30/2020 | kr2.81 B | $327.42 M | 88.93% | 14043 |
| 12/30/2019 | kr1.49 B | $169.39 M | 1.81% | 15533 |
| 12/28/2018 | kr1.46 B | $168.97 M | 41.36% | 14723 |
| 12/29/2017 | kr1.03 B | $125.92 M | 16807 |
Company Profile
BerGenBio ASA was founded in 2007 in Norway.
on the Oslo Børs.
With 13 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.
Frequently Asked Questions
-
What is BerGenBio ASA's (OSL-BGBIO) current market cap?As of 08/14/2025, BerGenBio ASA (including the parent company, if applicable) has an estimated market capitalization of $4.4 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does BerGenBio ASA (OSL-BGBIO) rank globally by market cap?BerGenBio ASA global market capitalization ranking is approximately 44566 as of 08/14/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.